Solana (HSDT) vs Hyperfine (HYPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hyperfine (HYPR) has outperformed Solana (HSDT) over the past year, losing 50.6% versus a loss of 86.0%. Over five years, HYPR leads with a -91.5% price change compared with -100.0% for HSDT. Solana is the larger company by market cap ($153.0 million vs $95.7 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSDT | HYPR |
|---|---|---|
| Share price | $2.35 | $0.9026 |
| Market cap | $153.00M | $95.72M |
| 1-day change | -7.48% | +6.29% |
| YTD return | -12.11% | -13.28% |
| 1-year return | -86.01% | -50.64% |
| 5-year return | -100.00% | -91.46% |
| P/E ratio (TTM) | 0.04 | — |
| EPS (TTM) | $53.74 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.97 | $2.22 |
| 52-week low | $1.19 | $0.754 |
| Distance from 52-week high | -86.92% | -59.34% |
| Analyst consensus | none | — |
| Avg. price target upside | +48.94% | — |
| Average volume | 349.89K | 611.89K |
| Shares outstanding | 65.10M | 90.99M |
| Employees | 21 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HYPR has outperformed HSDT by 35.4 percentage points over the past year.
About Solana
HSDT stock →Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees
HSDT vs HYPR FAQ
Which is bigger, Solana or Hyperfine?
Solana (HSDT) is larger, with a market capitalization of $153.00M compared with $95.72M for Hyperfine (HYPR).
Which stock has performed better over the past year, HSDT or HYPR?
HYPR returned -50.64% over the past 12 months, compared with -86.01% for HSDT (price return, excluding dividends). Past performance does not predict future results.
Are Solana and Hyperfine in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.